PharmEco Group of Companies

Search

RU | EN

BioJet – EN
  • About
    • General information
    • Administration
    • Pharmacovigilance
    • Business ethics
  • Production
  • Our products
  • News
  • Contacts

FMBA approves procedures for medical and sanitary measures in emergency response

The Federal Medical and Biological Agency of Russia (FMBA) has approved the Regulations for organizing and conducting medical and sanitary activities aimed at the prevention, containment, and elimination of the consequences of emergencies (EMEs) related to radiation, chemical, and biological incidents. These activities will be carried out by the functional subsystem of medical and sanitary aid to victims of emergencies within FMBA’s subordinate organizations.

The new procedure, which consists of 11 sections, specifies that non-regular (ad hoc) units will be established by FMBA institutions. According to the draft order, these units may include:

  • Combined mobile medical teams
  • Specialized medical care teams
  • Specialized anti-epidemic teams
  • Sanitary and epidemiological squads
  • First aid and pre-medical aid teams
  • Sanitary posts
  • Epidemiological reconnaissance groups
  • Clinical toxicology teams
  • Radiological response teams

These units will be staffed by specially trained FMBA personnel.

According to the agency’s directive, all specialists involved in these operations will be provided with personal protective equipment. The units will be equipped with specialized vehicles, instruments, and technical equipment in accordance with Russian Government Decree No. 379 of April 27, 2000, “On the accumulation, storage, and use of material, food, medical, and other supplies for civil defense purposes.”

The type, number, and readiness timelines for these non-regular units will be determined by the head of the FMBA.

Structural and Supervisory Changes

Until January 2020, the FMBA was under the jurisdiction of the Ministry of Health of Russia, after which it was transferred to the jurisdiction of the Government of the Russian Federation, and as of June 2024, it came under the President of Russia.

In January 2024, the agency also approved an internal regulation on organizing and conducting civil defense operations.

In January 2025, FMBA introduced a draft procedure for its segment of the Surveillance and Laboratory Monitoring Network (SLMN) for civil defense and population protection. This network will be composed of FMBA-affiliated institutions monitoring radiological, chemical, and biological environments in high-risk workplaces and specific regions of Russia. These institutions will carry out instrumental measurements and laboratory analyses of environmental samples. The draft outlines the core tasks, functions, modes of operation, and the subordination structure of the FMBA’s section of the network.

Source: Vademecum, April 16, 2025

Current news

  • January 13, 2026

    The average cost of bringing a medicinal product to market has tripled over 20 years

    Over the past 20 years, the average cost of bringing a medicinal product to market…

  • January 13, 2026

    More than 60% of the Russian pharmaceutical market is occupied by foreign drugmakers

    Despite sanctions and expectations of a complete withdrawal of foreign businesses, international pharmaceutical companies continue…

  • January 13, 2026

    The Ministry of Industry and Trade will align the regulatory framework with the transition to EAEU GMP

    The Ministry of Industry and Trade of Russia has prepared a draft government resolution proposing…

  • January 13, 2026

    WHO Director-General: Pandemic agreement to be opened for signature after May

    WHO member states are negotiating an important annex to the agreement — a pathogen access…

  • January 13, 2026

    The Ministry of Industry and Trade proposes extending transition periods related to confirmation of the country of origin of medicines and a number of medical devices

    Relevant draft amendments to resolutions of the Government of the Russian Federation*, prepared by the…

LLC “BioJet”. all rights reserved

  • Legal information